Pharmaceutical Executive October 22, 2024
Under terms of the deal, Sanofi would sell a 50% controlling stake in Opella to CD&R, while remaining a significant shareholder.
Sanofi and CD&R have announced a joint venture aimed at supporting the growth of Opella, a French healthcare company. According to Sanofi, the company would potentially sell a 50% controlling stake in Opella to CD&R, while staying on as a significant shareholder. The deal aims to set up Opella as a standalone, global leader in consumer healthcare with a focus on innovative medicines and vaccines, according to Sanofi.1
“We are proud of what Opella and its inspired people have already accomplished. We are confident that the future of Opella will be even brighter. We share the love and emotional...
Today's Sponsors
Today's Sponsor